| Medical and Health Sciences | 2021-2025 | 57 | US 27 | 99.99 |
| Dermatology | Lifetime | 4 | US 3 | 99.93 |
| Immunology and Allergy | Lifetime | 63 | US 30 | 99.01 |
| Immunology | Lifetime | 780 | US 399 | 97.49 |
| Urology | Lifetime | 312 | US 160 | 96.10 |
| Dermatology | 2021-2025 | 2 | US 2 | 99.98 |
| Immunology and Allergy | 2021-2025 | 6 | US 4 | 99.60 |
| Urology | 2021-2025 | 10 | US 6 | 99.35 |
| Medical Physiology | 2021-2025 | 196 | US 67 | 97.51 |
| Immunology | 2021-2025 | 187 | US 60 | 95.84 |
| Rheumatology | 2021-2025 | 192 | US 55 | 94.85 |
| Cell Biology | 2021-2025 | 105 | US 41 | 91.32 |
| Dermatology and Skin Diseases | Lifetime | 7 | US 5 | 99.90 |
| Allergic Rhinitis and Sensitization | Lifetime | 11 | US 4 | 99.90 |
| Asthma and respiratory diseases | Lifetime | 65 | US 24 | 99.78 |
| Urticaria and Related Conditions | Lifetime | 19 | US 9 | 99.58 |
| Food Allergy and Anaphylaxis Research | Lifetime | 54 | US 24 | 99.47 |
| IL-33, ST2, and ILC Pathways | Lifetime | 84 | US 41 | 99.08 |
| Hair Growth and Disorders | Lifetime | 39 | US 21 | 98.75 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 99 | US 38 | 99.04 |
| Contact Dermatitis and Allergies | Lifetime | 214 | US 53 | 98.02 |
| Autoimmune Bullous Skin Diseases | Lifetime | 336 | US 116 | 97.56 |
| melanin and skin pigmentation | Lifetime | 878 | US 315 | 93.02 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 2 | US 2 | 99.95 |
| Dermatology and Skin Diseases | 2021-2025 | 2 | US 2 | 99.94 |
| Asthma and respiratory diseases | 2021-2025 | 6 | US 2 | 99.87 |
| Food Allergy and Anaphylaxis Research | 2021-2025 | 4 | US 3 | 99.73 |
| Urticaria and Related Conditions | 2021-2025 | 6 | US 3 | 99.62 |
| Hair Growth and Disorders | 2021-2025 | 7 | US 4 | 99.35 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 15 | US 7 | 98.34 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 38 | US 13 | 98.35 |
| Contact Dermatitis and Allergies | 2021-2025 | 26 | US 7 | 97.51 |
| melanin and skin pigmentation | 2021-2025 | 70 | US 15 | 94.35 |
| T-cell and B-cell Immunology | 2021-2025 | 533 | US 217 | 89.15 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 235 | US 92 | 90.19 |
| Adrenal Hormones and Disorders | 2021-2025 | 246 | US 37 | 85.78 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 649 | US 108 | 86.55 |
| Nail Diseases and Treatments | 2021-2025 | 413 | US 91 | 82.35 |
| Dupuytren's Contracture and Treatments | 2021-2025 | 50 | US 19 | 73.83 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 379 | US 111 | 75.27 |
| RNA regulation and disease | 2021-2025 | 859 | US 227 | 70.45 |
| Transgenic Plants and Applications | 2021-2025 | 331 | US 63 | 72.38 |
| Skin and Cellular Biology Research | 2021-2025 | 436 | US 96 | 67.26 |
| Chemotherapy-related skin toxicity | 2021-2025 | 475 | US 162 | 51.52 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 769 | US 255 | 52.06 |